Search Results
Sep 10, 2026, 06:59 ET Simon® to Present at the BofA Securities 2026 Global Real Estate Conference
estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
Sep 09, 2026, 17:33 ET Simon Property Group Sells $800 Million of Senior Notes
estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
Sep 04, 2026, 19:15 ET Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
Simon Property GroupSPGReal Estate
More news about: S&P Dow Jones Indices
Aug 27, 2026, 12:00 ET Simon® Launches Simon Media Network™, Turning Real-World Consumer Behavior Into Measurable Business Impact
engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
Aug 10, 2026, 16:05 ET Simon® Reports Second Quarter 2026 Results and Increases Guidance for Full Year 2026 Real Estate FFO Per Share
engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
Jul 16, 2026, 08:30 ET Spinogenix Announces World Health Organization Approval of "Codabakalner" as International Nonproprietary Name for SPG601
developing two novel therapeutics: Tazbentetol (SPG302), which is designed to trigger neurons to produce new glutamatergic synapses and restore cognitive, motor, and other functions in ALS, Alzheimer's disease, schizophrenia and other diseases; and codabakalner (SPG601), which is designed to work at the synaptic
More news about: Spinogenix
Jul 14, 2026, 13:56 ET Spinogenix Reports Positive Data on Alzheimer's Patients Who Continued Treatment With Tazbentetol For Up To 84 Weeks
dysfunction. Spinogenix is developing two novel therapeutics: Tazbentetol (SPG302), a synaptic regenerative therapy designed to restore cognitive, motor, and other functions in Alzheimer's disease, ALS, schizophrenia and other diseases; and SPG601, a synaptic corrective therapy designed to work at the BK channel
More news about: Spinogenix
Jul 14, 2026, 07:07 ET Safety Products Global Launches FoodProtect™ Series to Close a Gap Most Food Safety Plans Don't Know They Have
lines.*IRVINE, Calif., July 14, 2026 /PRNewswire/ -- Safety Products Global (SPG) today announced the launch of the FoodProtect™ Series, a controlled cutting system purpose-built for food processing and manufacturing facilities. Combining
More news about: Safety Products Global
Jul 09, 2026, 08:30 ET Spinogenix Appoints Harvard Medical School Professor of Neurology Steven E. Arnold, MD, to Scientific Advisory Board
developing two novel therapeutics: Tazbentetol (SPG302), which is designed to trigger neurons to produce new glutamatergic synapses and restore cognitive, motor, and other functions in ALS, Alzheimer's disease, schizophrenia and other diseases; and SPG601, which is designed to work at the synaptic level
More news about: Spinogenix
Jul 02, 2026, 08:30 ET Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board
developing two novel therapeutics: Tazbentetol (SPG302), which is designed to trigger neurons to produce new glutamatergic synapses and restore cognitive, motor, and other functions in ALS, Alzheimer's disease, schizophrenia and other diseases; and SPG601, which is designed to work at the synaptic level
More news about: Spinogenix
Jul 01, 2026, 16:10 ET Simon® Announces Date For Its Second Quarter 2026 Earnings Release And Conference Call
engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
Jul 01, 2026, 09:15 ET 198± AC QUARRY IN HUDSON VALLEY AVAILABLE VIA BANKRUPTCY SALE WITH HILCO GLOBAL
investment with long-term value potential."The sale is subject to approval by U.S. Bankruptcy Court Eastern District of New York, Case No. 8-2670730-spg, In re: Speyside Holdings, LLC, and in cooperation with Jonathan Cuticelli, NY Broker, Lic. #10351218305. Bids are due by August 14 and must
More news about: Hilco Trading, LLC
Jun 15, 2026, 08:30 ET Spinogenix Recognizes Dr. Craig Erickson following $17.25 Million Autism Research Grant to Cincinnati Children's Hospital
developing two novel therapeutics: Tazbentetol (SPG302), which is designed to trigger neurons to produce new glutamatergic synapses and restore cognitive, motor, and other functions in ALS, Alzheimer's disease, schizophrenia and other diseases; and SPG601, which is designed to work at the synaptic level
More news about: Spinogenix
Jun 11, 2026, 08:06 ET Diamond Brew, America's First Brewless Coffee Pod, Closes Oversubscribed Seven-Figure Pre-Seed Round
today announced the close of an oversubscribed pre-seed funding round. Investors include G/7 Venture Studio, Filipp Chebotarev of Cambridge Companies SPG, Beckett Industries, SGL Acquisitions, LLC, music executive and strategic advisor Charlie Walk, Kingsland Capital Group, Nobel Partners, Daniel Faierman
More news about: Diamond Brew Coffee
Jun 09, 2026, 16:15 ET Simon Property Group Announces Offering of Euro-Denominated Notes
leader in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
Jun 09, 2026, 09:30 ET Canyon Further Expands Asset-Backed Finance Platform with Launch of Canyon ABF Partners
structured credit. Mr. Kim was previously Head of Fixed Income and Securitized Products at Credit Suisse, where he led the Securitized Products Group (SPG) which dominated league tables for the decade prior to its sale to Apollo and rebranding as ATLAS SP. In addition to Mr. Kim, CAP's Investment Committee
More news about: Canyon Partners, LLC
Jun 08, 2026, 09:00 ET Simon Premium Outlets® Announces Retail's Biggest Experiential Shopping Event, National Outlet Shopping Day®, at 90 Destinations
engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
May 28, 2026, 12:56 ET Simon® is Teaming up with adidas® to Offer Fan Experiences for a Summer of Global Soccer
engaged in the ownership of premier shopping, dining, and entertainment mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
May 11, 2026, 16:05 ET Simon® Reports First Quarter 2026 Results, Increases Full Year 2026 Real Estate FFO Per Share Guidance and Raises Quarterly Dividend
engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon
May 06, 2026, 07:16 ET Safety Products Global Appoints Gregory J. Gluchowski Jr. to Board of Directors
firsthand how he thinks about growth, talent, and enterprise value. SPG is in a similar moment, redefining what safe looks like in a category undergoing rapid transformation, and Greg's perspective will sharpen how we get there.""SPG is operating at the intersection of two things I care about deeply,
More news about: Safety Products Global
May 05, 2026, 08:30 ET Spinogenix Receives U.S. FDA Fast Track Designation for Tazbentetol for the Treatment of ALS
developing two novel therapeutics: Tazbentetol (SPG302), which is designed to trigger neurons to produce new glutamatergic synapses and restore cognitive, motor, and other functions in ALS, Alzheimer's disease, schizophrenia and other diseases; and SPG601, which is designed to work at the synaptic level
More news about: Spinogenix
May 03, 2026, 08:43 ET Spinogenix to Present Preclinical Results at ARVO 2026 Demonstrating Neuroprotective Effects of Tazbentetol in Glaucoma and Diabetic Retinopathy Models
developing two novel therapeutics: Tazbentetol (SPG302), which is designed to trigger neurons to produce new glutamatergic synapses and restore cognitive, motor, and other functions in ALS, Alzheimer's disease, schizophrenia and other diseases; and SPG601, which is designed to work at the synaptic level
More news about: Spinogenix
Apr 23, 2026, 08:30 ET Spinogenix Announces CLARITY: a Phase 2b/3 trial of SPG601 for the Treatment of Fragile X Syndrome
Sarraf, CEO and Founder of Spinogenix. "We remain committed to supporting this community through advancing SPG601 to the next stage of clinical development."About SPG601SPG601 is an oral investigational medication being developed to treat FXS, and potentially other conditions on
More news about: Spinogenix
Apr 15, 2026, 12:30 ET At Accelerate 2026, Vertafore Honors Insurance Leaders for Turning Velocity into Action
services. With its expansion through strategic acquisitions, SPG has focused on delivering a consistent, high-quality digital experience for retail agencies across its entire organization. By bringing together AIM™ and Surefyre™, SPG is creating a seamless, end-to-end experience that makes
More news about: Vertafore, Inc.
Apr 14, 2026, 16:10 ET Simon® Announces Date For Its First Quarter 2026 Earnings Release And Conference Call
engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual
More news about: Simon